Kaci Kennedy Mcdade
Biographic Data
| ID | 7581156 |
|---|---|
| NAME | Kaci Kennedy Mcdade |
| GIVEN NAMES | Kaci Kennedy |
| FAMILY NAME | Mcdade |
| SIGNATURE | MCDADE K K |
| AFFILIATIONS | Duke University |
| ORCID | 0000-0002-0469-229X |
| VERIFIED | Yes |
| TOTAL WORKS | 11 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 11 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
United Kingdom aid cuts
Background: The United Kingdom (UK) used to be the second largest bilateral provider of official development assistance (ODA) for health. However, in 2021 the UK government cut its annual aid budget by 30%. We aim to understand how these cuts might affect financing for health systems in UK aid recipient countries. Methods: We conducted a retrospective analysis of domestic and external funding for 134 countries that received UK aid for the 2019-20…
Investing in a global pooled-funding mechanism for late-stage clinical trials of poverty-related and neglected diseases
INTRODUCTION: Poverty-related and neglected diseases (PRNDs) cause over three million deaths annually. Despite this burden, there is a large gap between actual funding for PRND research and development (R&D) and the funding needed to launch PRND products from the R&D pipeline. This study provides an economic evaluation of a theoretical global pooled-funding mechanism to finance late-stage clinical trials of PRND products. METHODS: We modelled thr…
Strategic donor behaviour and country vulnerability in health aid transitions
BACKGROUND: When countries reach the middle-income threshold, many multilateral donors, including Gavi, the Vaccine Alliance (Gavi), begin to withdraw their official development assistance (ODA), known as graduation. We hypothesised that bilateral donors might follow Gavi's lead, except in countries where they have strategic interests. We aim to understand how bilateral donors behave after a recipient country graduates from Gavi support and how b…
Chinese health funding in Africa
The motivations behind China’s allocation of health aid to Africa remain complex due to limited information on the details of health aid project activities. Insufficient knowledge about the purpose of China’s health aid hinders our understanding of China’s comprehensive role in supporting Africa’s healthcare system. To address this gap, our study aimed to gain better insights into China’s health aid priorities and the factors driving these priori…
Tracking financing for global common goods for health
Objective: Tracking global health funding is a crucial but time consuming and labor-intensive process. This study aimed to develop a framework to automate the tracking of global health spending using natural language processing (NLP) and machine learning (ML) algorithms. We used the global common goods for health (CGH) categories developed by Schäferhoff et al. to design and evaluate ML models. Methods: We used data curated by Schäferhoff et al.,…
Estimating Chinese bilateral aid for health
BACKGROUND: Although it is difficult to quantify, previous estimates suggested that China's global health aid has increased sharply since the early 2000s. Unlike many donors, China has no official aid reporting obligations, nor does it voluntarily disclose detailed aid information. Our study aimed to create a standardised estimate using commonly accepted definitions of aid and frameworks for categorising health projects. METHODS: We categorised A…
Identifying the impact of Covid-19 on health systems and lessons for future emergency preparedness
The coronavirus pandemic (COVID-19) has triggered a public health and economic crisis in high and low resource settings since the beginning of 2020. With the first case being discovered on 12 th March 2020, Kenya has responded by using health and non-health strategies to mitigate the direct and indirect impact of the disease on its population. However, this has had positive and negative implications for the country’s overall health system. This p…
The impacts of donor transitions on health systems in middle-income countries
As countries graduate from low-income to middle-income status, many face losses in development assistance for health and must ‘transition’ to greater domestic funding of their health response. If improperly managed, donor transitions in middle-income countries (MICs) could present significant challenges to global health progress. No prior knowledge synthesis has comprehensively surveyed how donor transitions can affect health systems in MICs. We …
Transitioning from donor aid for health
BACKGROUND: Ghana's shift from low-income to middle-income status will make it ineligible to receive concessional aid in the future. While transition may be a reflection of positive changes in a country, such as economic development or health progress, a loss of support from donor agencies could have negative impacts on health system performance and population health. We aimed to identify key challenges and opportunities that Ghana will face in d…
Making sense of estimates of health aid from China
The global aid landscape is rapidly changing. So-called ‘emerging’ or ‘non-traditional’ donors (ie, those that have only recently substantially stepped up their development finance support) are pushing the boundaries of existing aid practices. Among such non-traditional donors, China stands out as a major player because of its recent high-profile commitments, like the Belt and Road Initiative, and its major role in establishing new development fi…
Incentivising wealthy nations to participate in the Covid-19 Vaccine Global Access Facility (Covax)
box Progress in developing COVID-19 vaccines has been rapid: the first clinical trial of a vaccine candidate began in Seattle, USA on 16 March 2020—just 63 days after China shared the genetic sequence of SARS-CoV-2, the virus that causes COVID-19. As of 12 November 2020, there were 48 candidate vaccines in clinical trials.1 Given standard attrition rates, we can expect at least a handful of COVID-19 vaccines to eventually be launched. However, de…
No prominent works on this page.
Making sense of estimates of health aid from China
The global aid landscape is rapidly changing. So-called ‘emerging’ or ‘non-traditional’ donors (ie, those that have only recently substantially stepped up their development finance support) are pushing the boundaries of existing aid practices. Among such non-traditional donors, China stands out as a major player because of its recent high-profile commitments, like the Belt and Road Initiative, and its major role in establishing new development fi…
Incentivising wealthy nations to participate in the Covid-19 Vaccine Global Access Facility (Covax)
box Progress in developing COVID-19 vaccines has been rapid: the first clinical trial of a vaccine candidate began in Seattle, USA on 16 March 2020—just 63 days after China shared the genetic sequence of SARS-CoV-2, the virus that causes COVID-19. As of 12 November 2020, there were 48 candidate vaccines in clinical trials.1 Given standard attrition rates, we can expect at least a handful of COVID-19 vaccines to eventually be launched. However, de…
Transitioning from donor aid for health
BACKGROUND: Ghana's shift from low-income to middle-income status will make it ineligible to receive concessional aid in the future. While transition may be a reflection of positive changes in a country, such as economic development or health progress, a loss of support from donor agencies could have negative impacts on health system performance and population health. We aimed to identify key challenges and opportunities that Ghana will face in d…
Tracking financing for global common goods for health
Objective: Tracking global health funding is a crucial but time consuming and labor-intensive process. This study aimed to develop a framework to automate the tracking of global health spending using natural language processing (NLP) and machine learning (ML) algorithms. We used the global common goods for health (CGH) categories developed by Schäferhoff et al. to design and evaluate ML models. Methods: We used data curated by Schäferhoff et al.,…
Estimating Chinese bilateral aid for health
BACKGROUND: Although it is difficult to quantify, previous estimates suggested that China's global health aid has increased sharply since the early 2000s. Unlike many donors, China has no official aid reporting obligations, nor does it voluntarily disclose detailed aid information. Our study aimed to create a standardised estimate using commonly accepted definitions of aid and frameworks for categorising health projects. METHODS: We categorised A…
Identifying the impact of Covid-19 on health systems and lessons for future emergency preparedness
The coronavirus pandemic (COVID-19) has triggered a public health and economic crisis in high and low resource settings since the beginning of 2020. With the first case being discovered on 12 th March 2020, Kenya has responded by using health and non-health strategies to mitigate the direct and indirect impact of the disease on its population. However, this has had positive and negative implications for the country’s overall health system. This p…
The impacts of donor transitions on health systems in middle-income countries
As countries graduate from low-income to middle-income status, many face losses in development assistance for health and must ‘transition’ to greater domestic funding of their health response. If improperly managed, donor transitions in middle-income countries (MICs) could present significant challenges to global health progress. No prior knowledge synthesis has comprehensively surveyed how donor transitions can affect health systems in MICs. We …
United Kingdom aid cuts
Background: The United Kingdom (UK) used to be the second largest bilateral provider of official development assistance (ODA) for health. However, in 2021 the UK government cut its annual aid budget by 30%. We aim to understand how these cuts might affect financing for health systems in UK aid recipient countries. Methods: We conducted a retrospective analysis of domestic and external funding for 134 countries that received UK aid for the 2019-20…
Investing in a global pooled-funding mechanism for late-stage clinical trials of poverty-related and neglected diseases
INTRODUCTION: Poverty-related and neglected diseases (PRNDs) cause over three million deaths annually. Despite this burden, there is a large gap between actual funding for PRND research and development (R&D) and the funding needed to launch PRND products from the R&D pipeline. This study provides an economic evaluation of a theoretical global pooled-funding mechanism to finance late-stage clinical trials of PRND products. METHODS: We modelled thr…
Strategic donor behaviour and country vulnerability in health aid transitions
BACKGROUND: When countries reach the middle-income threshold, many multilateral donors, including Gavi, the Vaccine Alliance (Gavi), begin to withdraw their official development assistance (ODA), known as graduation. We hypothesised that bilateral donors might follow Gavi's lead, except in countries where they have strategic interests. We aim to understand how bilateral donors behave after a recipient country graduates from Gavi support and how b…
Chinese health funding in Africa
The motivations behind China’s allocation of health aid to Africa remain complex due to limited information on the details of health aid project activities. Insufficient knowledge about the purpose of China’s health aid hinders our understanding of China’s comprehensive role in supporting Africa’s healthcare system. To address this gap, our study aimed to gain better insights into China’s health aid priorities and the factors driving these priori…
Business (9 works) · Economic growth (8 works) · Economics (8 works) · Global Maternal and Child Health (8 works) · Medicine (7 works) · Political science (7 works) · Healthcare Systems and Reforms (5 works) · Environmental health (4 works) · International Development and Aid (4 works) · Developing country (3 works)